Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2025-12-24 @ 5:04 PM
NCT ID:
NCT03760250
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or greater
* Men and women who present clinically with keloids requesting excision
* Any number of keloids
* Keloid no larger than 5cm in diameter at the base
* Clinical findings consistent with keloid formation
* Location of keloid in low-risk areas - areas other than above the neck, hands, feet, or groin
* Able and willing to give informed consent
Exclusion Criteria:
* Age \< 18
* Hypersensitivity to Imiquimod or to any of the excipients (methylhydroxybenzoate, propylhydroxybenzoate, cetyl alcohol, and stearyl alcohol)
* Involvement in a trial of another experimental intervention within 30 days
* Life threatening disease
* Use of immunosuppressive medications such as oral corticosteroids
* Bleeding disorders
* Not available for follow-up for 10 weeks
* Pregnant, intention to become pregnant during treatment phase of trial, or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03760250
Study Brief:
Protocol Section:
NCT03760250